The 2-Minute Rule for Healthcare News
Novo CEO pressed by Senate to cut prices of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would take into account new talks with insurers in regards to the listing prices of Wegovy and copyright when they pledge to help keep the med